Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan

被引:43
作者
Hwang, Shang-Jyh [2 ,3 ]
Lin, Ming-Yen [2 ]
Chen, Hung-Chun [2 ,3 ]
Hwang, Su-Chen [4 ]
Yang, Wu-Chang [5 ,6 ]
Hsu, Chih-Cheng [7 ]
Chiu, Herng-Chia [8 ]
Mau, Lih-Wen [1 ,8 ]
机构
[1] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan
[5] Natl Yang Ming Univ, Vet Gen Hosp Taipei, Dept Med, Div Nephrol, Zuhnan, Taiwan
[6] Natl Yang Ming Univ, Sch Med, Zuhnan, Taiwan
[7] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Zuhnan, Taiwan
[8] Kaohsiung Med Univ, Inst Healthcare Adm, Kaohsiung, Taiwan
基金
美国国家卫生研究院;
关键词
chronic kidney disease; elderly population; epidemiology and outcomes; glomerular filtration rate; mortality risk;
D O I
10.1093/ndt/gfn222
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 [基础医学]; 1002 [临床医学]; 100602 [中西医结合临床];
摘要
Background. Taiwan has the world's highest incidence and second highest prevalence of end-stage renal disease (ESRD), particularly in older age groups. However, the transition from chronic kidney disease (CKD) to death or ESRD remains unclear. This study aimed to investigate the impact of late-stage CKD on all-cause and cause-specific mortality by identifying the CKD population. Methods. This was an observational cohort study (n = 35 529), mean age 75.7 years (SD = 5.3), of participants in the Elderly Health Examination Program (EHEP) in Kaohsiung City, Taiwan, between 2002 and 2004. Estimated glomerular filtration rate (eGFR) was calculated by the simplified modified diet in renal disease equation. Proportional hazard ratios (HR) of mortality associated with late-stage CKD were assessed by Cox regression. Results. The crude prevalence rate of CKD stages 3-5 was 39.4%; 1840 participants (5.18%) died within 2-year follow-up, a mortality rate of 20.3 per 1000 person-years overall and 16.4 per 1000 person-years in the reference group. Higher HR for all-cause and cause-specific mortality were found in the groups with decreased eGFR. Compared with the reference group (eGFR > 60 mL/min/1.73 m(2)), adjusted HR for all-cause mortality were 1.5, 2.1 and 2.6 for groups with eGFR 30-44, 15-29 and < 15 mL/min/ 1.73 m(2), respectively (P < 0.001). Higher HR of mortality due to cardiovascular or renal diseases were also significantly associated with decreased eGFR (P < 0.05). Conclusion. Late-stage CKD is a significant risk factor for mortality, especially due to cardiovascular and renal diseases, in elderly Taiwanese. Given the higher prevalence rate of late-stage CKD in the study area, CKD patient mortality was relatively lower, which might reflect underestimation of renal function for patients at early stages of CKD, or partly explain the high ESRD population.
引用
收藏
页码:3192 / 3198
页数:7
相关论文
共 26 条
[1]
[Anonymous], 2002, Am J Kidney Dis
[2]
Mortality within the first 10 years of the disease in type 2 diabetic patients [J].
Bo, S ;
Ciccone, G ;
Gancia, R ;
Rosato, R ;
Grassi, G ;
Merletti, F ;
Pagano, GF .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (01) :8-12
[3]
Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 3 diabetes [J].
Bruno, G ;
Merletti, F ;
Biggeri, A ;
Bargero, G ;
Ferrero, S ;
Runzo, C ;
Cerai, SP ;
Pagano, G ;
Cavallo-Perin, P .
DIABETES CARE, 2004, 27 (11) :2689-2694
[4]
Chronic kidney disease and cardiovascular disease in the Medicare population [J].
Collins, AJ ;
Li, SL ;
Gilbertson, DT ;
Liu, JN ;
Chen, SC ;
Herzog, CA .
KIDNEY INTERNATIONAL, 2003, 64 :S24-S31
[5]
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[6]
*DEP HLTH, 2004, AG SPEC MORT RAT LEA
[7]
*DEP HLTH, 1994, HLTH VIT STAT 2, V2
[8]
The burden of kidney disease: Improving global outcomes [J].
Eknoyan, G ;
Lameire, N ;
Barsoum, R ;
Eckardt, KU ;
Levin, A ;
Levin, N ;
Locatelli, F ;
MacLeod, A ;
Vanholder, R ;
Walker, R ;
Wang, HY .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1310-1314
[9]
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].
Ford, ES .
DIABETES CARE, 2005, 28 (07) :1769-1778
[10]
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305